Related Experiment Video
Updated: Jul 10, 2026

08:26
Assessing Activity-based Anorexia in Mice
Published on: May 14, 2018
GLP-1 Receptor Agonism Exacerbates Activity-Based Anorexia in Mice
Amit Thakar1, Travis E Brown1, Shane T Hentges1
1Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, Washington, USA.
The International Journal of Eating Disorders
|July 9, 2026
Summary
Glucagon-like peptide-1 receptor (GLP-1R) agonists worsen anorexia nervosa outcomes by increasing weight loss and reducing food intake in a rodent model. These findings caution against using GLP-1R agonists in individuals prone to restrictive eating behaviors.
Area of Science:
- Neuroscience
- Endocrinology
- Eating Disorders Research
Background:
- Glucagon-like peptide-1 receptor (GLP-1R) agonists are known to reduce food intake and body weight.
- Preclinical data suggested GLP-1R agonists might mitigate hyperactivity and reward-seeking behavior, potentially benefiting anorexia nervosa (AN).
- Activity-based anorexia (ABA) is a rodent model used to study AN pathology, characterized by hyperactivity and weight loss.
Purpose of the Study:
- To investigate the effects of GLP-1R agonists on weight loss and hyperactivity in a rodent model of activity-based anorexia (ABA).
- To determine if GLP-1R agonism could attenuate compulsive-like hyperactivity or worsen outcomes in ABA.
Main Methods:
- Female mice were subjected to ABA conditions with running wheel access and restricted feeding.
- Systemic administration of a GLP-1R agonist, antagonist, or vehicle was performed daily before food presentation.
- Key parameters monitored included weight loss, food intake, and wheel running activity.
Main Results:
- GLP-1R agonist treatment significantly exacerbated weight loss in the ABA model.
- This worsening was attributed to further suppressed food intake, with no change in wheel running activity.
- Pharmacological blockade of GLP-1R signaling did not affect ABA parameters compared to controls.
Conclusions:
- GLP-1R agonism worsens outcomes in an animal model of anorexia nervosa, contrary to initial hypotheses.
- Endogenous GLP-1 signaling does not appear to play a significant role in ABA pathology.
- Caution is advised for using GLP-1R agonists in individuals at risk for AN due to potential exacerbation of weight loss and reduced food intake.
Related Concept Videos
Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...

